Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | FTO | Q9C0B1 | 9/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.40 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.40 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.40 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20340166 | 0.97 | MEN1 (0.41) | ALDH1A1HPGDTDP1CYP3A4HIF1A | |
| SCHEMBL11993611 | 0.96 | ALDH1A1 (0.46) | ALDH1A1HPGDTDP1CYP3A4HIF1A | |
| SCHEMBL29569825 | 0.96 | ALDH1A1 (0.46) | ALDH1A1HPGDTDP1CYP3A4HIF1A | |
| SCHEMBL20967763 | 0.88 | ALDH1A1 (0.39) | ALDH1A1HPGDTDP1CYP3A4HIF1A | |
| SCHEMBL29579867 | 0.88 | FTO (0.55) | ALDH1A1HPGDTDP1CYP3A4HSD17B10 | |
| SCHEMBL19360153 | 0.87 | CYP3A4 (0.40) | ALDH1A1HPGDTDP1CYP3A4HSD17B10 | |
| SCHEMBL29349733 | 0.86 | MAPT (0.62) | ALDH1A1HPGDTDP1CYP3A4HSD17B10 | |
| SCHEMBL31580193 | 0.85 | FTO (0.55) | ALDH1A1HPGDTDP1CYP3A4HSD17B10 | |
| SCHEMBL334086 | 0.85 | FTO (0.55) | ALDH1A1HPGDTDP1CYP3A4HSD17B10 | |
| SCHEMBL29383733 | 0.85 | FTO (0.55) | ALDH1A1HPGDTDP1CYP3A4HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114755415-A | Combined factor induced degradation type endothelial cell and method for treating hepatic fibrosis diseases | 清华大学 | 2022-07-15 | — | — | CN | claimed |
| WO-2024237764-A9 | PROBE FOR MEASURING CATHEPSIN K ACTIVITY AND COMPOSITION FOR DIAGNOSING BONE DISEASE COMPRISING SAME | 고려대학교 산학협력단 | 2025-03-13 | — | — | WO | disclosed |
| WO-2024237764-A2 | PROBE FOR MEASURING CATHEPSIN K ACTIVITY AND COMPOSITION FOR DIAGNOSING BONE DISEASE COMPRISING SAME | 고려대학교 산학협력단 | 2024-11-21 | — | — | WO | disclosed |
| EP-4425179-A2 | COMPOSITIONS AND METHODS FOR ENHANCED FLUORESCENCE | Life Technologies Corporation (US) | 2024-09-04 | — | — | EP | disclosed |
| EP-3507603-B1 | COMPOSITIONS AND METHODS FOR ENHANCED FLUORESCENCE | LIFE TECHNOLOGIES CORP (US) | 2024-03-06 | — | — | EP | disclosed |
| US-20240042062-A1 | COMPOSITIONS AND METHODS FOR ENHANCED FLUORESCENCE | Life Technologies Corporation (US) | 2024-02-08 | — | — | US | disclosed |
| US-11865191-B2 | Compositions and methods for enhanced fluorescence | Life Technologies Corporation (US) | 2024-01-09 | — | — | US | disclosed |
| WO-2022183370-A1 | ELECTRIC CELL IMPEDANCE SENSING-BASED METHOD FOR ANTITUMOR MEDICAMENT SCREENING | 北京大学 | 2022-09-09 | — | — | WO | disclosed |
| CN-114755415-A | Combined factor induced degradation type endothelial cell and method for treating hepatic fibrosis diseases | 清华大学 | 2022-07-15 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240042062-A1 | COMPOSITIONS AND METHODS FOR ENHANCED FLUORESCENCE | ANXA5, HNRNPF, ANXA6 | ALDH1A1 2920/4885HPGD 3776/4885TDP1 335/4885 |
| US-11865191-B2 | Compositions and methods for enhanced fluorescence | ANXA5, HNRNPF, ANXA6 | ALDH1A1 2920/4885HPGD 3776/4885TDP1 335/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.